These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37307132)

  • 21. Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study.
    Infante M; Buoso A; Pieri M; Lupisella S; Nuccetelli M; Bernardini S; Fabbri A; Iannetta M; Andreoni M; Colizzi V; Morello M
    J Am Nutr Assoc; 2022; 41(3):250-265. PubMed ID: 33600292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The intercorrelations between blood levels of ferritin, sCD163, and IL-18 in COVID-19 patients and their association to prognosis.
    Volfovitch Y; Tsur AM; Gurevitch M; Novick D; Rabinowitz R; Mandel M; Achiron A; Rubinstein M; Shoenfeld Y; Amital H
    Immunol Res; 2022 Dec; 70(6):817-828. PubMed ID: 36222965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Investigation of the Relationship of Systemic Immune-Inflammation Index, C-Reactive Protein and Interleukin-6 with Viral Dynamics in Patients with COVID-19].
    Salman E; Çelikbilek N; Aydoğan S; Özdem B; Gökay S; Kırca F; Toyran A; Bilici Salman R; Dinç B
    Mikrobiyol Bul; 2021 Oct; 55(4):539-552. PubMed ID: 34666654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.
    Wang M; Zhu Q; Fu J; Liu L; Xiao M; Du Y
    Infect Genet Evol; 2020 Nov; 85():104511. PubMed ID: 32858231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do Laboratory Biomarkers Predict Survival In Severe Covid-19? A Cross-Sectional Study.
    Bahadur S; Rahim F; Amin S; Noor M; Gul H; Mahmood A; Usman M; Ullah R; Khan MA; Shahab K
    J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S919-S922. PubMed ID: 36550644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double blinded placebo controlled comparative clinical trial to evaluate the effectiveness of Siddha medicines, Kaba Sura Kudineer (KSK) & Nilavembu Kudineer (NVK) along with standard Allopathy treatment in the management of symptomatic COVID 19 patients - a structured summary of a study protocol for a randomized controlled trial.
    Srivastava A; Rengaraju M; Srivastava S; Narayan V; Gupta V; Upadhayay R
    Trials; 2021 Feb; 22(1):130. PubMed ID: 33573696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary Involvement in SARS-CoV-2 Infection Estimates Myocardial Injury Risk.
    Dumea E; Lazar M; Barbu EC; Chitu CE; Ion DA
    Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295594
    [No Abstract]   [Full Text] [Related]  

  • 29. Early use of tocilizumab in the prevention of adult respiratory failure in SARS-CoV-2 infections and the utilization of interleukin-6 levels in the management.
    Antony SJ; Davis MA; Davis MG; Almaghlouth NK; Guevara R; Omar F; Del Rey F; Hassan A; Arian MU; Antony N; Prakash BV
    J Med Virol; 2021 Jan; 93(1):491-498. PubMed ID: 32644254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of laboratory parameters in predicting severity of COVID-19 disease in pregnant patients.
    Sahin O; Aktoz F; Bagci H; Vurgun E
    J Obstet Gynaecol; 2022 Aug; 42(6):1917-1921. PubMed ID: 35603633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological and biochemical biomarker alterations among SARS-COV-2 patients with varying disease phenotypes in Uganda.
    Kato CD; Nsubuga J; Niyonzima N; Kitibwa A; Matovu E; Othieno E; Ssebugere P; Tumwine AA; Namayanja M
    BMC Infect Dis; 2023 Dec; 23(1):857. PubMed ID: 38057707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
    Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
    Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-inflammatory response of cardamom extract and prediction of therapeutic window in COVID-19 patients by assessing inflammatory markers using RT-PCR.
    Shakeeb N; Varkey P; Hynse A; Mandlecha A
    Inflammopharmacology; 2022 Jun; 30(3):883-894. PubMed ID: 35320494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Characteristics and Immune Responses of 137 Deceased Patients With COVID-19: A Retrospective Study.
    Cui N; Yan R; Qin C; Zhao J
    Front Cell Infect Microbiol; 2020; 10():595333. PubMed ID: 33365277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interpretation of Hematological, Biochemical, and Immunological Findings of COVID-19 Disease: Biomarkers Associated with Severity and Mortality.
    Ghazanfari T; Salehi MR; Namaki S; Arabkheradmand J; Rostamian A; Rajabnia Chenary M; Ghaffarpour S; Kaboudanian Ardestani S; Edalatifard M; Naghizadeh MM; Mohammadi S; Mahloujirad M; Izadi A; Ghanaati H; Beigmohammadi MT; Vodjgani M; Mohammad Shirazi B; Mirsharif ES; Abdollahi A; Mohammadi M; Emadi Kouchak H; Dehghan Manshadi SA; Zamani MS; Mahmoodi Aliabadi M; Jamali D; Khajavirad N; Mohseni Majd AM; Nasiri Z; Faghihzadeh S
    Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):46-66. PubMed ID: 33639632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients.
    Fathalla LA; Kamal LM; Salaheldin O; Khalil MA; Kamel MM; Fahim HH; Abdel-Moneim YA; Abdulhakim JA; Abdel-Moneim AS; El-Meligui YM
    Int J Immunopathol Pharmacol; 2022; 36():3946320221096207. PubMed ID: 35622504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A composite risk model predicts disease progression in early stages of COVID-19: A propensity score-matched cohort study.
    Xu J; Gao Y; Hu S; Li S; Wang W; Wu Y; Su Z; Zhou X; Cheng X; Zheng Q
    Ann Clin Biochem; 2021 Sep; 58(5):434-444. PubMed ID: 33827266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of IL-6, ferritin, and coagulopathy in Covid-19 clinical progression.
    Harahap AT; Irawan C; Susilo A; Harimurti K; Gathmyr D; Shatri H; Lubis AM; Nainggolan L; Abdullah M
    F1000Res; 2022; 11():1285. PubMed ID: 37841828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analyzing Correlation of Clinical Severity of COVID-19 with Other Biochemical Parameters: A Retrospective Study from Pakistan.
    Hassan Shah SST; Naeem I; Wahid B
    Tohoku J Exp Med; 2021 Dec; 255(4):315-323. PubMed ID: 34911879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.